Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Mark Rubinstein   and   Zihai Li.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.631
         
        
        
     
 
    
        
        - 
            Cancer immunotherapy: are we there yet? Exp Hematol Oncol. 2013 Dec 10; 2(1):33.
            
            
                Score: 0.438
            
         
        
        - 
            Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-?. Sci Transl Med. 2020 01 08; 12(525).
            
            
                Score: 0.167
            
         
        
        - 
            Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. J Hematol Oncol. 2018 12 21; 11(1):142.
            
            
                Score: 0.155
            
         
        
        - 
            IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 02; 38(2):45-68.
            
            
                Score: 0.146
            
         
        
        - 
            Platelets subvert T cell immunity against cancer via GARP-TGF? axis. Sci Immunol. 2017 May 05; 2(11).
            
            
                Score: 0.139
            
         
        
        - 
            Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. Cancer Immunol Immunother. 2017 Jun; 66(6):737-751.
            
            
                Score: 0.137
            
         
        
        - 
            Harnessing the IL-7/IL-7Ra axis to improve tumor immunotherapy. Oncoimmunology. 2016 May; 5(5):e1122865.
            
            
                Score: 0.127
            
         
        
        - 
            IL-2Ra mediates temporal regulation of IL-2 signaling and enhances immunotherapy. Sci Transl Med. 2015 Oct 28; 7(311):311ra170.
            
            
                Score: 0.125
            
         
        
        - 
            Differential immune signatures in the tumor microenvironment are associated with colon cancer racial disparities. Cancer Med. 2021 03; 10(5):1805-1814.
            
            
                Score: 0.045
            
         
        
        - 
            IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors. Cancer Res. 2020 09 15; 80(18):3920-3932.
            
            
                Score: 0.043
            
         
        
        - 
            Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines. Front Immunol. 2019; 10:263.
            
            
                Score: 0.039
            
         
        
        - 
            ?-catenin and PI3Kd inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. JCI Insight. 2017 Apr 20; 2(8).
            
            
                Score: 0.035
            
         
        
        - 
            Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer. J Hematol Oncol. 2017 04 07; 10(1):82.
            
            
                Score: 0.034